AiCuris
Phase 3Delivering Novel Anti-Viral Therapies to patients with weakened immune systems We are driven to meet the needs of the growing population of immunocompromised pe
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $390M
About
Delivering Novel Anti-Viral Therapies to patients with weakened immune systems We are driven to meet the needs of the growing population of immunocompromised pe
Small Molecules
Funding History
7Total raised:$390M
Series D$110MSep 15, 2019
Series C$75MMar 15, 2015
Series C$75MJun 15, 2014
Series B$40MJun 15, 2010